Tesamorelin / lpamorelin
A research blend combining Tesamorelin and Ipamorelin to study synergistic effects on the growth hormone axis and metabolic pathways.
About Tesamorelin / lpamorelin
This formulation pairs Tesamorelin, a stabilized GHRH analog, with Ipamorelin, a selective ghrelin receptor (GHSR-1a) agonist, to examine coordinated growth hormone signaling through dual mechanisms. Tesamorelin is widely researched for its extended receptor activation and influence on IGF-1 and metabolic balance, while Ipamorelin provides clean, pulse-based stimulation of GH release with minimal off-target endocrine impact. Together, the 10mg/3mg ratio offers a distinct profile for studying GH rhythm enhancement, pituitary responsiveness, and metabolic pathway modulation. Researchers utilize this combination to model enhanced GH amplitude, endocrine crosstalk, and synergistic regulatory patterns.
